Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.
Researchers
Manuel Weber, Elena Gimeno-Santos, Marieke Wuyts, Beatriz Herrero-Cortina, Thierry Troosters, Milo A Puhan
Abstract
Guidelines have provided positive recommendations for pulmonary rehabilitation after severe exacerbations of chronic obstructive pulmonary disease (COPD), but results are heterogeneous and new randomised controlled trials (RCTs) continue to be published. To assess the effects of pulmonary rehabilitation after COPD exacerbations on hospital admissions (critical outcome) and other important and patient-centred outcomes (mortality, health-related quality of life (HRQL) and exercise capacity). We identified studies through searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE ALL, Embase, ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP). Searches were current to 2 June 2026. RCTs comparing pulmonary rehabilitation of any duration (at least exercise training but no minimum number of exercise sessions) after exacerbation of COPD versus usual care were eligible. Usual care groups received conventional community care without rehabilitation. The four main outcomes were hospital readmissions, mortality, HRQL and exercise capacity. We assessed the risk of bias in the included RCTs as high, low or unclear, using the Cochrane RoB 1 tool. We expected substantial heterogeneity across trials due to the diversity of rehabilitation programmes (i.e. number of completed exercise sessions; type, intensity and supervision of exercise training; and patient education), duration of follow-up (under three months versus three months or longer) and risk of bias (random sequence generation, allocation concealment and blinding). Therefore, we conducted prespecified subgroup analyses. We used random-effects models and standard Cochrane methods for this update, and assessed the certainty of evidence using GRADE. For this update, we added 20 studies and included a total of 40 studies (2825 participants). Rehabilitation programmes showed great diversity in terms of exercise training (number of completed exercise sessions; type, intensity and supervision), patient education (from none to extensive self-management programmes) and how they were organised (within one setting, e.g. pulmonary rehabilitation, to across several settings, e.g. hospital, outpatient centre and home). In 12 studies, participants completed extensive pulmonary rehabilitation, and in 25 studies, participants completed pulmonary rehabilitation ranging from not extensive to moderately extensive. We could not determine how extensive the programmes were in three studies, owing to missing information. Thirteen studies (1229 participants) contributed data on hospital readmissions, with follow-up ranging from three months to 18 months. Moderate-certainty evidence indicates that pulmonary rehabilitation after an exacerbation likely reduces the risk of hospital readmission when compared with usual care (pooled odds ratio (OR) 0.52, 95% confidence interval (CI) 0.32 to 0.84; I<sup>2</sup> = 69%). Twenty-two studies (1677 participants) contributed data on all-cause mortality, but only 11 trials (1196 participants) were included in the pooled effect estimate because the remaining studies reported no deaths in either group. Follow-up in these studies ranged from the duration of the hospital stay to 48 months. Low-certainty evidence suggests that pulmonary rehabilitation after an exacerbation may reduce all-cause mortality slightly when compared with usual care (pooled OR 0.84, 95% CI 0.49 to 1.43; I<sup>2</sup> = 33%). Twelve studies (1118 participants) used the St George's Respiratory Questionnaire (SGRQ) to assess HRQL, with follow-up ranging from the duration of the hospital stay to 12 months. High-certainty evidence indicates that, when compared with usual care, pulmonary rehabilitation after an exacerbation results in a large improvement in HRQL, as measured by the SGRQ total score (mean difference (MD) -9.05, 95% CI -12.60 to -5.50; I<sup>2</sup> = 70%), exceeding the minimal important difference (MID) of four points. There was evidence of a difference between pulmonary rehabilitation and usual care for the SGRQ activity and impacts domains (effects exceeding the MID), but no evidence of a difference for the symptoms domain. Twenty-two studies (1464 participants) used the six-minute walk distance (6MWD) to assess exercise capacity, with follow-up ranging from four days to 208 weeks. High-certainty evidence indicates that pulmonary rehabilitation after an exacerbation results in a large improvement in 6MWD when compared with usual care (MD 57.79 m, 95% CI 41.68 to 73.91; I<sup>2</sup> = 89%). Heterogeneity appeared to be driven mainly by differences between studies showing very large effects and those showing smaller effects but still evidence of between-group differences. The overall results of this review have not changed to an important extent compared with results reported in the previous version of this review. Overall, the risk of bias was judged to be low or unclear across most domains. However, the lack of participant blinding raised concerns for subjectively reported outcomes (HRQL). High risks of selection bias and attrition bias were identified in a small number of studies, while a larger proportion of studies were at high risk for reporting bias. Egger's test indicated evidence of funnel plot asymmetry for hospital readmission (P = 0.02) and mortality (P = 0.02), but not for SGRQ (P = 0.45) or the six-minute walk test (P = 0.12). Visual inspection suggested that the asymmetry was more consistent with small-study effects than with clear evidence of missing negative studies. Moderate-certainty evidence indicates that pulmonary rehabilitation likely reduces hospital readmissions, while evidence for mortality is of low certainty. However, some recent studies showed no benefit of rehabilitation on hospital readmissions and mortality. Such heterogeneity of effects on hospital readmissions and mortality may be explained to some extent by the extensiveness of rehabilitation programmes and by the methodological quality of the included studies. High-certainty evidence shows moderate to large effects of pulmonary rehabilitation on HRQL and exercise capacity in people with COPD after an exacerbation. While additional RCTs comparing rehabilitation to no rehabilitation seem questionable scientifically and ethically, future research must investigate how rehabilitation programmes can be designed and implemented to be feasible, cost-effective and attractive and accessible for patients and healthcare providers in the long term. Research must also investigate how the organisation of such programmes within specific healthcare systems determines their effects after COPD exacerbations on hospital readmissions and mortality. This Cochrane review had no dedicated funding. Protocol (2005) DOI: 10.1002/14651858.CD005305 Original review (2009) DOI: 10.1002/14651858.CD005305.pub2 Review update (2011) DOI: 10.1002/14651858.CD005305.pub3 Review update (2016) DOI: 10.1002/14651858.CD005305.pub4.Source: PubMed (PMID: 43042775)View Original on PubMed